Treating Temporomandibular Disorders in the 21st Century: Can We Finally Eliminate the “Third Pathway”?

Within the orofacial pain discipline, the most common group of afflictions is temporomandibular disorders (TMD). The pathologic and functional disorders included in this condition closely resemble those that are seen in the orthopedic medicine branch of the medical profession, so it would be expected that the same principles of orthopedic diagnosis and treatment are applied. Traditional orthopedic therapy relies on a “Two Pathway” approach involving conservative and/or surgical treatments. However, over the course of the 20th century, some members of the dental community have created another way of approaching these disorders—referred to in this paper as the “Third Pathway”—based on the assumption that signs and symptoms of TMD are due to a “bad” relationship between the mandible and skull, leading to a variety of irreversible occlusal or surgical corrective treatments. Since no other human joint is discussed in these terms within the orthopedic medicine communities, it has become progressively clear that the Third Pathway is a unique and artificial conceptual creation of the dental profession. However, many clinical studies have utilized the medically oriented conservative/surgical Two-Pathway model to diagnose and treat TMD within a biopsychosocial model of pain. These studies have shown that TMD comprise another domain of orthopedic illness that requires a medically oriented approach for good outcomes while avoiding the irreversible aspects of the Third Pathway. This review presents historical and current evidence that the Third Pathway is an example of unorthodox medicine that leads to unnecessary overtreatment and further proposes that it is time to abandon this approach as we move forward in the TMD field.

dental occlusion; jaw repositioning; orthopedics; temporomandibular disorders; TMD

1. Schiffman E, Ohrbach R. Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications. J Am Dent Assoc 2016;147:438–445.

2. Laskin DM, Renapurkar SK. Current controversies in the management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2018;30:xiii.

3. McNeill C. Management of temporomandibular disorders: Concepts and controversies. J Prosthet Dent 1997;77:510–522.

4. Friedman MH. Therapeutic condylar repositioning: Fact or fancy? Quintessence Int 1985;16:195–199.

5. Piehslinger E, Celar A, Celar R, Jäger W, Slavicek R. Reproducibility of the condylar reference position. J Orofac Pain 1993;7:68–75.

6. Weinberg LA. Definitive prosthodontic therapy for TMJ patients. Part I: Anterior and posterior condylar displacement. J Prosthet Dent 1983;50:544–557.

7. Costen JB. A syndrome of ear and sinus symptoms dependent upon disturbed function of the temporomandibular joint. Ann Otol Rhinol Laryngol 1934;43:1–15.

8. Manfredini D, Lombardo L, Siciliani G. Temporomandibular disorders and dental occlusion. A systematic review of associ-ation studies: End of an era? J Oral Rehabil 2017;44:908–923.

9. Türp JC, Schindler H. The dental occlusion as a suspected cause for TMDs: Epidemiological and etiological considerations. J Oral Rehabil 2012;39:502–512.

10. Rinchuse DJ, Kandasamy S. Myths of orthodontic gnathology. Am J Orthod Dentofacial Orthop 2009;136:322–330.

11. Manfredini D. Occlusal equilibration for the management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2018;30:257–264.

12. Lundh H, Westesson PL, Jisander S, Eriksson L. Disk-repositioning onlays in the treatment of temporomandibular joint disk displacement: Comparison with a flat occlusal splint and with no treatment. Oral Surg Oral Med Oral Pathol 1988;66:155–162.

13. Westesson PL, Lundh H. Temporomandibular joint disk displacement: Arthrographic and tomographic follow-up after 6 months’ treatment with disk-repositioning onlays. Oral Surg Oral Med Oral Pathol 1988;66:271–278.

14. Okeson JP. Long-term treatment of disk-interference disorders of the temporomandibular joint with anterior repositioning occlusal splints. J Prosthet Dent 1988;60:611–616.

15. Anderson GC, Schulte JK, Goodkind RJ. Comparative study of two treatment methods for internal derangement of the temporomandibular joint. J Prosthet Dent 1985;53:392–397.

16. Greene CS. A critique of nonconventional treatment concepts and procedures for TMJ disorders. Compend Contin Educ Dent 1984;5:848–851,854.

17. Zamburlini I, Austin D. Long-term results of appliance therapies in anterior disk displacement with reduction: A review of the literature. Cranio 1991;9:361–368.

18. Greene CS, Obrez A. Treating temporomandibular disorders with permanent mandibular repositioning: Is it medically necessary? Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:489–498.

19. Manfredini D, Ahlberg J, Winocur E, Guarda-Nardini L, Lobbezoo F. Correlation of RDC/TMD axis I diagnoses and axis II pain-related disability. A multicenter study. Clin Oral Investig 2011;15:749–756.

20. Ohrbach R, Dworkin SF. The evolution of TMD diagnosis: Past, present, future. J Dent Res 2016;95:1093–1101.

21. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

22. De Leeuw R, Klasser GD. Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management, ed 6. Chicago: Quintessence, 2018.

23. American Association of Oral and Maxillofacial Surgeons. Parameters of Care: Clinical Practice Guidelines for Oral and Maxillofacial Surgery (AAOMS ParCare 2017), Sixth Edition. Rosemont, IL: AAOMS, 2017.

24. De Boever JA, Nilner M, Orthlieb JD, Steenks MH; Educational Committee of the European Academy of Craniomandibular Disorders. Recommendations by the EACD for examination, diagnosis, and management of patients with temporomandibular disorders and orofacial pain by the general dental practi-tioner. J Orofac Pain 2008;22:268–278.

25. Rinchuse DJ, Kandasamy S. Centric relation: A historical and contemporary orthodontic perspective. J Am Dent Assoc 2006;137:494–501.

26. Türp JC, Schlenker A, Schröder J, Essig M, Schmitter M. Disk displacement, eccentric condylar position, osteoarthrosis—Misnomers for variations of normality? Results and interpretations from an MRI study in two age cohorts. BMC Oral Health 2016;16:124.

27. Lelis ÉR, Guimarães Henriques JC, Tavares M, de Mendonça MR, Fernandes Neto AJ, Almeida Gde A. Conebeam tomography assessment of the condylar position in asymptomatic and symptomatic young individuals. J Prosthet Dent 2015;114:420–425.

28. Vozzi F, Favero L, Peretta R, Guarda-Nardini L, Cocilovo F, Manfredini D. Indexes of jaw muscle function in asymptomatic individuals with different occlusal features. Clin Exp Dent Res 2018;4:263–267.

29. Manfredini D, Cocilovo F, Favero L, Ferronato G, Tonello S, Guarda-Nardini L. Surface electromyography of jaw muscles and kinesiographic recordings: Diagnostic accuracy for myofascial pain. J Oral Rehabil 2011;38:791–799.

30. Ramfjord SP, Ash MM. Occlusion, ed 2. Philadelphia: W.B. Saunders, 1971.

31. Greene CS, Laskin DM. Splint therapy for the myofascial pain—Dysfunction (MPD) syndrome: A comparative study. J Am Dent Assoc 1972;84:624–628.

32. Goodman P, Greene CS, Laskin DM. Response of patients with myofascial pain-dysfunction syndrome to mock equilibration. J Am Dent Assoc 1976;92:755–758.

33. Dahlström L, Carlsson GE, Carlsson SG. Comparison of effects of electromyographic biofeedback and occlusal splint therapy on mandibular dysfunction. Scand J Dent Res 1982; 90:151–156.

34. Okeson JP, Moody PM, Kemper JT, Calhoun TC. Evaluation of occlusal splint therapy. J Craniomandibular Pract 1983;1: 47–52.

35. Greene CS, Menchel HF. The use of oral appliances in the management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2018;30:265–277.

36. Dao TT, Lavigne GJ. Oral splints: The crutches for temporomandibular disorders and bruxism? Crit Rev Oral Biol Med 1998;9:345–361.

37. Dimitroulis G. Temporomandibular joint surgery: What does it mean to the dental practitioner? Aust Dent J 2011;56:257–264.

38. Koslin MG, Indresano AT, Mercuri LG. Temporomandibular joint surgery. J Oral Maxillofac Surg 2012;70(11 suppl 3): e204–e231.

39. Dolwick MF. Temporomandibular joint surgery for internal derangement. Dent Clin North Am 2007;51:195–208.

40. Melis M, Zawawi KH. Occlusal dysesthesia: A topical narrative review. J Oral Rehabil 2015;42:779–785.

41. Cioffi I, Michelotti A, Perrotta S, Chiodini P, Ohrbach R. Ef-fect of somatosensory amplification and trait anxiety on experimentally induced orthodontic pain. Eur J Oral Sci 2016; 124:127–134.

42. Manfredini D, Landi N, Romagnoli M, Cantini E, Bosco M. Etiopathogenesis of parafunctional habits of the stomatognathicsystem. Minerva Stomatol 2003;52:339–349.

43. Manfredini D, Bucci MB, Montagna F, Guarda-Nardini L. Temporomandibular disorders assessment: Medicolegal considerations in the evidence-based era. J Oral Rehabil 2011; 38:101–119.

44. Slade GD, Ohrbach R, Greenspan JD, et al. Painful temporo-mandibular disorder: Decade of discovery from OPPERA studies. J Dent Res 2016;95:1084–1092.

45. Huttunen J, Qvintus V, Suominen AL, Sipilä K. Role of psychosocial factors on treatment outcome of temporomandibular disorders. Acta Odontol Scand 2019;77:119–125.

46. Wolford LM, Reiche-Fischel O, Mehra P. Changes in temporomandibular joint dysfunction after orthognathic surgery. J Oral Maxillofac Surg 2003;61:655–660.

47. Bucci MB, Aversa M, Guarda-Nardini L, Manfredini D. Occlusion and temporomandibular disorders: A malpractice case with medical legal considerations. Minerva Stomatol 2011; 60:65–74.

48. Kurita K, Westesson PL, Yuasa H, Toyama M, Machida J, Ogi N. Natural course of untreated symptomatic temporomandibular joint disc displacement without reduction. J Dent Res 1998;77:361–365.

49. de Bont LG, Dijkgraaf LC, Stegenga B. Epidemiology and natural progression of articular temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:72–76.

50. Stohler CS. Phenomenology, epidemiology, and natural progression of the muscular temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:77–81.

51. Manfredini D, Favero L, Gregorini G, Cocilovo F, Guar-da-Greene L. Natural course of temporomandibular disorders with low pain-related impairment: A 2-to-3-year follow-up study. J Oral Rehabil 2013;40:436–442.

52. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med 2008;359:2693–2705.

53. Laskin DM. Arthroscopy versus arthrocentesis for treating internal derangements of the temporomandibular joint. Oral Maxillofac Surg Clin North Am 2018;30:325–328.

54. Forssell H, Kauko T, Kotiranta U, Suvinen T. Predictors for future clinically significant pain in patients with temporoman-dibular disorder: A prospective cohort study. Eur J Pain 2017; 21:188–197.

55. Kapos FP, Look JO, Zhang L, Hodges JS, Schiffman EL. Predictors of long-term temporomandibular disorder pain intensity: An 8-year cohort study. J Oral Facial Pain Headache 2018;32:113–122.

56. Ohrbach R, Fillingim RB, Mulkey F, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12 (11 suppl):T27–T45.

57. Greene CS, Laskin DM. Long-term evaluation of conservative treatment for myofascial pain-dysfunction syndrome. J Am Dent Assoc 1974;89:1365–1368.

58. Whitney CW, Von Korff M. Regression to the mean in treated versus untreated chronic pain. Pain 1992;50:281–285.

59. Greene CS, Goddard G, Macaluso GM, Mauro G. Topical review: Placebo responses and therapeutic responses. How are they related? J Orofac Pain 2009;23:93–107.

60. Porporatti AL, Costa YM, Réus JC, et al. Placebo and nocebo response magnitude on temporomandibular disorder-related pain: A systematic review and meta-analysis. J Oral Rehabil 2019;46:862–882.

61. Laskin DM. Temporomandibular disorders: A term past its time? J Am Dent Assoc 2008;139:124–128.

62. Costa YM, Conti PC, de Faria FA, Bonjardim LR. Temporo-mandibular disorders and painful comorbidities: Clinical association and underlying mechanisms. Oral Surg Oral Med OralPathol Oral Radiol 2017;123:288–297.

63. Dahan H, Shir Y, Velly A, Allison P. Specific and number of comorbidities are associated with increased levels of temporo-mandibular pain intensity and duration. J Headache Pain 2015; 16:528.

64. Laskin DM, Greene CS. Influence of the doctor-patient relationship on placebo therapy for patients with myofascial pain-dysfunction (MPD) syndrome. J Am Dent Assoc 1972; 85:892–894.